psymberin and Carcinoma

psymberin has been researched along with Carcinoma* in 1 studies

Other Studies

1 other study(ies) available for psymberin and Carcinoma

Article	Year
Irciniastatin A, a pederin-type translation inhibitor, promotes ectodomain shedding of cell-surface tumor necrosis factor receptor 1. The Journal of antibiotics, 2015, Volume: 68, Issue:6 Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Membrane; Cell Nucleus; Cell Survival; Coumarins; Gene Expression Regulation, Neoplastic; Humans; Intercellular Adhesion Molecule-1; Lung Neoplasms; Molecular Weight; Neoplasm Proteins; Osmolar Concentration; Protein Biosynthesis; Protein Synthesis Inhibitors; Protein Transport; Proteolysis; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction	2015

Article

Year

Irciniastatin A, a pederin-type translation inhibitor, promotes ectodomain shedding of cell-surface tumor necrosis factor receptor 1.

The Journal of antibiotics, 2015, Volume: 68, Issue:6

Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Membrane; Cell Nucleus; Cell Survival; Coumarins; Gene Expression Regulation, Neoplastic; Humans; Intercellular Adhesion Molecule-1; Lung Neoplasms; Molecular Weight; Neoplasm Proteins; Osmolar Concentration; Protein Biosynthesis; Protein Synthesis Inhibitors; Protein Transport; Proteolysis; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction

2015